More Like this

1. Allosteric activation or inhibition of PI3Kγ mediated through conformational changes in the p110γ helical domain

   https://doi.org/10.7554/eLife.88058.3  

   Harris, Noah J; Jenkins, Meredith L; Nam, Sung-Eun; Rathinaswamy, Manoj K; Parson, Matthew AH; Ranga-Prasad, Harish; Dalwadi, Udit; Moeller, Brandon E; Sheeky, Eleanor; Hansen, Scott D; et al (July 2023, eLife)

   Andreotti, Amy H (Ed.)

   PI3Kγ is a critical immune signaling enzyme activated downstream of diverse cell surface molecules, including Ras, PKCβ activated by the IgE receptor, and Gβγ subunits released from activated GPCRs. PI3Kγ can form two distinct complexes, with the p110γ catalytic subunit binding to either a p101 or p84 regulatory subunit, with these complexes being differentially activated by upstream stimuli. Here, using a combination of cryo electron microscopy, HDX-MS, and biochemical assays, we have identified novel roles of the helical domain of p110γ in regulating lipid kinase activity of distinct PI3Kγ complexes. We defined the molecular basis for how an allosteric inhibitory nanobody potently inhibits kinase activity through rigidifying the helical domain and regulatory motif of the kinase domain. The nanobody did not block either p110γ membrane recruitment or Ras/Gβγ binding, but instead decreased ATP turnover. We also identified that p110γ can be activated by dual PKCβ helical domain phosphorylation leading to partial unfolding of an N-terminal region of the helical domain. PKCβ phosphorylation is selective for p110γ-p84 compared to p110γ-p101, driven by differential dynamics of the helical domain of these different complexes. Nanobody binding prevented PKCβ-mediated phosphorylation. Overall, this work shows an unexpected allosteric regulatory role of the helical domain of p110γ that is distinct between p110γ-p84 and p110γ-p101 and reveals how this can be modulated by either phosphorylation or allosteric inhibitory binding partners. This opens possibilities of future allosteric inhibitor development for therapeutic intervention. 

   more » « less
2. A multiple-step in silico screening protocol to identify allosteric inhibitors of Spike–hACE2 binding

   https://doi.org/10.1039/d1cp04736a  

   Zhai, Jingchen; He, Xibing; Man, Viet Hoang; Sun, Yuchen; Ji, Beihong; Cai, Lianjin; Wang, Junmei (February 2022, Physical Chemistry Chemical Physics)

   While the COVID-19 pandemic continues to worsen, effective medicines that target the life cycle of SARS-CoV-2 are still under development. As more highly infective and dangerous variants of the coronavirus emerge, the protective power of vaccines will decrease or vanish. Thus, the development of drugs, which are free of drug resistance is direly needed. The aim of this study is to identify allosteric binding modulators from a large compound library to inhibit the binding between the Spike protein of the SARS-CoV-2 virus and human angiotensin-converting enzyme 2 (hACE2). The binding of the Spike protein to hACE2 is the first step of the infection of host cells by the coronavirus. We first built a compound library containing 77 448 antiviral compounds. Molecular docking was then conducted to preliminarily screen compounds which can potently bind to the Spike protein at two allosteric binding sites. Next, molecular dynamics simulations were performed to accurately calculate the binding affinity between the spike protein and an identified compound from docking screening and to investigate whether the compound can interfere with the binding between the Spike protein and hACE2. We successfully identified two possible drug binding sites on the Spike protein and discovered a series of antiviral compounds which can weaken the interaction between the Spike protein and hACE2 receptor through conformational changes of the key Spike residues at the Spike–hACE2 binding interface induced by the binding of the ligand at the allosteric binding site. We also applied our screening protocol to another compound library which consists of 3407 compounds for which the inhibitory activities of Spike/hACE2 binding were measured. Encouragingly, in vitro data supports that the identified compounds can inhibit the Spike–ACE2 binding. Thus, we developed a promising computational protocol to discover allosteric inhibitors of the binding of the Spike protein of SARS-CoV-2 to the hACE2 receptor, and several promising allosteric modulators were discovered. 

   more » « less
3. Multi-Substituted Quinolines as HIV-1 Integrase Allosteric Inhibitors

   https://doi.org/10.3390/v14071466  

   Dinh, Long Phi; Sun, Jian; Glenn, Courtney D.; Patel, Krunal; Pigza, Julie A.; Donahue, Matthew G.; Yet, Larry; Kessl, Jacques J. (July 2022, Viruses)

   Allosteric HIV-1 integrase (IN) inhibitors, or ALLINIs, are a new class of antiviral agents that bind at the dimer interface of the IN, away from the enzymatic catalytic site and block viral replication by triggering an aberrant multimerization of the viral enzyme. To further our understanding of the important binding features of multi-substituted quinoline-based ALLINIs, we have examined the IN multimerization and antiviral properties of substitution patterns at the 6 or 8 position. We found that the binding properties of these ALLINIs are negatively impacted by the presence of bulky substitutions at these positions. In addition, we have observed that the addition of bromine at either the 6 (6-bromo) or 8 (8-bromo) position conferred better antiviral properties. Finally, we found a significant loss of potency with the 6-bromo when tested with the ALLINI-resistant IN A128T mutant virus, while the 8-bromo analog retained full effectiveness. 

   more » « less
4. F1FO ATP synthase molecular motor mechanisms

   https://doi.org/10.3389/fmicb.2022.965620  

   Frasch, Wayne D.; Bukhari, Zain A.; Yanagisawa, Seiga (August 2022, Frontiers in Microbiology)

   The F-ATP synthase, consisting of F 1 and F O motors connected by a central rotor and the stators, is the enzyme responsible for synthesizing the majority of ATP in all organisms. The F 1 (αβ) 3 ring stator contains three catalytic sites. Single-molecule F 1 rotation studies revealed that ATP hydrolysis at each catalytic site (0°) precedes a power-stroke that rotates subunit-γ 120° with angular velocities that vary with rotational position. Catalytic site conformations vary relative to subunit-γ position (β E , empty; β D , ADP bound; β T , ATP-bound). During a power stroke, β E binds ATP (0°–60°) and β D releases ADP (60°–120°). Årrhenius analysis of the power stroke revealed that elastic energy powers rotation via unwinding the γ-subunit coiled-coil. Energy from ATP binding at 34° closes β E upon subunit-γ to drive rotation to 120° and forcing the subunit-γ to exchange its tether from β E to β D , which changes catalytic site conformations. In F 1 F O , the membrane-bound F O complex contains a ring of c-subunits that is attached to subunit-γ. This c-ring rotates relative to the subunit-a stator in response to transmembrane proton flow driven by a pH gradient, which drives subunit-γ rotation in the opposite direction to force ATP synthesis in F 1 . Single-molecule studies of F 1 F O embedded in lipid bilayer nanodisks showed that the c-ring transiently stopped F 1 -ATPase-driven rotation every 36° (at each c-subunit in the c 10 -ring of E. coli F 1 F O ) and was able to rotate 11° in the direction of ATP synthesis. Protonation and deprotonation of the conserved carboxyl group on each c-subunit is facilitated by separate groups of subunit-a residues, which were determined to have different pKa’s. Mutations of any of any residue from either group changed both pKa values, which changed the occurrence of the 11° rotation proportionately. This supports a Grotthuss mechanism for proton translocation and indicates that proton translocation occurs during the 11° steps. This is consistent with a mechanism in which each 36° of rotation the c-ring during ATP synthesis involves a proton translocation-dependent 11° rotation of the c-ring, followed by a 25° rotation driven by electrostatic interaction of the negatively charged unprotonated carboxyl group to the positively charged essential arginine in subunit-a. 

   more » « less
5. Mapping protein dynamics at high spatial resolution with temperature-jump X-ray crystallography

   https://doi.org/10.1038/s41557-023-01329-4  

   Wolff, Alexander M.; Nango, Eriko; Young, Iris D.; Brewster, Aaron S.; Kubo, Minoru; Nomura, Takashi; Sugahara, Michihiro; Owada, Shigeki; Barad, Benjamin A.; Ito, Kazutaka; et al (September 2023, Nature Chemistry)

   Abstract Understanding and controlling protein motion at atomic resolution is a hallmark challenge for structural biologists and protein engineers because conformational dynamics are essential for complex functions such as enzyme catalysis and allosteric regulation. Time-resolved crystallography offers a window into protein motions, yet without a universal perturbation to initiate conformational changes the method has been limited in scope. Here we couple a solvent-based temperature jump with time-resolved crystallography to visualize structural motions in lysozyme, a dynamic enzyme. We observed widespread atomic vibrations on the nanosecond timescale, which evolve on the submillisecond timescale into localized structural fluctuations that are coupled to the active site. An orthogonal perturbation to the enzyme, inhibitor binding, altered these dynamics by blocking key motions that allow energy to dissipate from vibrations into functional movements linked to the catalytic cycle. Because temperature jump is a universal method for perturbing molecular motion, the method demonstrated here is broadly applicable for studying protein dynamics. 

   more » « less